- AU$310.77m
- AU$276.48m
- AU$3.42m
Australia Stock Exchange release from RACE ONCOLOGY LT : MD Anderson Preclinical AML Study on Zantrene Published
Brief: Race Oncology Appoints Christina Manfre, As CFO
Australia Stock Exchange release from RACE ONCOLOGY LT : Appointment of Chief Financial Officer
Australia Stock Exchange release from RACE ONCOLOGY LT : Quarterly Activity Report & Appendix 4C
Australia Stock Exchange release from RACE ONCOLOGY LT : PRE_NR Ends: 12:04:04
Australia Stock Exchange release from RACE ONCOLOGY LT : Race Receives FY2021 $708k R&D Tax Refund
Brief: Race Oncology Says Non-Executive Chairman, John Cullity Has Sold 300,000 Race Shares
Australia Stock Exchange release from RACE ONCOLOGY LT : Appendix 3Y - Dr John Cullity
Brief: Race Oncology Raises Full A$29.7 Million In Share Purchase Plan
Australia Stock Exchange release from RACE ONCOLOGY LT : Application for quotation of securities - RAC
Australia Stock Exchange release from RACE ONCOLOGY LT : Appendix 3Y - Phillip Lynch
Australia Stock Exchange release from RACE ONCOLOGY LT : Appendix 3Y - Dr Daniel Tillett
Australia Stock Exchange release from RACE ONCOLOGY LT : Appendix 3Y - Mary Harney
Australia Stock Exchange release from RACE ONCOLOGY LT : Change in substantial holding
Australia Stock Exchange release from RACE ONCOLOGY LT : PRE_NR Ends: 09:53:38
Australia Stock Exchange release from RACE ONCOLOGY LT : Race raises $29.7 million in oversubscribed SPP
Australia Stock Exchange release from RACE ONCOLOGY LT : Change of Registry Address
Australia Stock Exchange release from RACE ONCOLOGY LT : Appendix 3Y - Dr Daniel Tillett
Australia Stock Exchange release from RACE ONCOLOGY LT : SPP Closing Deadline Reminder & Investor Briefing Recording